MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 238 filers reported holding MIRATI THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $268,774 | -24.0% | 7,229 | -7.4% | 0.02% | -30.4% |
| Q4 2022 | $353,826 | -26.6% | 7,809 | +13.2% | 0.02% | -25.8% |
| Q3 2022 | $482,000 | -9.1% | 6,898 | -12.7% | 0.03% | +10.7% |
| Q2 2022 | $530,000 | -0.6% | 7,899 | +22.0% | 0.03% | 0.0% |
| Q1 2022 | $533,000 | +133.8% | 6,477 | +316.5% | 0.03% | +100.0% |
| Q4 2021 | $228,000 | -72.7% | 1,555 | -67.0% | 0.01% | -70.2% |
| Q3 2021 | $834,000 | +0.6% | 4,714 | -8.2% | 0.05% | +4.4% |
| Q2 2021 | $829,000 | -20.7% | 5,133 | -15.9% | 0.04% | -25.0% |
| Q1 2021 | $1,045,000 | -27.9% | 6,103 | -7.5% | 0.06% | -42.9% |
| Q4 2020 | $1,449,000 | -58.1% | 6,596 | -68.3% | 0.10% | -6.2% |
| Q3 2020 | $3,456,000 | +1014.8% | 20,812 | +185.1% | 0.11% | +1500.0% |
| Q4 2018 | $310,000 | +19.2% | 7,300 | +32.4% | 0.01% | +40.0% |
| Q3 2018 | $260,000 | – | 5,513 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |